Inter Miami CF Renews Longstanding Multilayered Partnership with Baptist Health
-
March 18, 2026
-
4 min
March 18, 2026
A human-in-the-loop AI strategy helped narrow more than 10,000 candidates to a CAR T target now validated in mouse models
July 6, 2026
Roswell Park Comprehensive Cancer Center announces the release of a new operative surgical manual authored by Khurshid Guru, MD.
Dana-Farber Cancer Institute's Dr. Sara Tolaney presented a subgroup analysis of the ASCENT-04 study based on biomarkers. Across all subgroups, patients who received sacituzumab govitecan plus pembro as first-line therapy had longer progression-free survival compared to standard therapy.
July 1, 2026